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Increased number of circulating 
exosomes and their microRNA cargos are 
potential novel biomarkers in alcoholic hepatitis
Fatemeh Momen‑Heravi†, Banishree Saha†, Karen Kodys, Donna Catalano, Abhishek Satishchandran 
and Gyongyi Szabo*
Abstract 
Background: It has been well documented that alcohol and its metabolites induce injury and inflammation in the 
liver. However, there is no potential biomarker to monitor the extent of liver injury in alcoholic hepatitis patients. 
MicroRNAs (miRNAs) are a class of non‑coding RNAs that are involved in various physiologic and pathologic pro‑
cesses. In the circulation, a great proportion of miRNAs is associated with extracellular vesicles (EVs)/exosomes. Here, 
we hypothesized that the exosome‑associated miRNAs can be used as potential biomarkers in alcoholic hepatitis 
(AH).
Methods: Exosomes were isolated from sera of alcohol‑fed mice or pair‑fed mice, and plasma of alcoholic hepatitis 
patients or healthy controls by ExoQuick. The exosomes were characterized by transmission electron microscopy and 
Western blot and enumerated with a Nanoparticle Tracking Analysis system. Firefly™ microRNA Assay was performed 
on miRNA extracted from mice sera. TaqMan microRNA assay was used to identify differentially expressed miRNAs 
in plasma of cohort of patients with AH versus controls followed by construction of receiver operating characteristic 
(ROC) curves to determine the sensitivity and specificity of the candidates.
Results: The total number of circulating EVs was significantly increased in mice after alcohol feeding. Those EVs 
mainly consisted of exosomes, the smaller size vesicle subpopulation of EVs. By performing microarray screening on 
exosomes, we found nine inflammatory miRNAs which were deregulated in sera of chronic alcohol‑fed mice com‑
pared to controls including upregulated miRNAs: miRNA‑192, miRNA‑122, miRNA‑30a, miRNA‑744, miRNA‑1246, 
miRNA 30b and miRNA‑130a. The ROC analyses indicated excellent diagnostic value of miRNA‑192, miRNA‑122, and 
miRNA‑30a to identify alcohol‑induced liver injury. We further validated findings from our animal model in human 
samples. Consistent with the animal model, total number of EVs, mostly exosomes, was significantly increased in 
human subjects with AH. Both miRNA‑192 and miRNA‑30a were significantly increased in the circulation of subjects 
with AH. miRNA‑192 showed promising value for the diagnosis of AH.
Conclusion: Elevated level of EVs/exosomes and exosome‑associated miRNA signature could serve as potential diag‑
nostic markers for AH. In addition to the biomarker diagnostic capabilities, these findings may facilitate development 
of novel strategies for diagnostics, monitoring, and therapeutics of AH.
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Liquid biopsy, Human, miRNA
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Background
Alcoholic hepatitis (AH) is an acute hepatic inflamma-
tion accompanied with substantial morbidity and mor-
tality and increasing health problems across the world. 
AH is a result of the complex interactions between etha-
nol metabolism, inflammation, and innate immunity on 
the liver [1]. Currently the enzymatic activity of alanine 
aminotransferase (ALT) and aspartate aminotransferase 
(AST) in blood are the most commonly used indicators 
for detection of liver damage; however, increased serum 
ALT- and AST are not specific for the type of liver disease, 
the extent of liver damage or the absence or presence of 
liver inflammation. In addition, ALT/AST increase is not 
specific to AH and occurs in many other liver disorders [2, 
3]. Moreover, these two diagnostic markers do not always 
correlate well with the disease stage and extent of hepato-
cellular damage or liver fibrosis [3].
MicroRNAs (miRNAs) are small (17–25 nucleotide 
long) non-coding RNAs that regulate gene expression 
post-transcriptionally [4, 5]. miRNAs play important 
roles in different pathogenesis pathways and can be 
deregulated in different diseases. A growing body of evi-
dence shows that miRNAs can act as novel biomarkers 
for diagnosis and therapeutic monitoring of various dis-
eases such as cancers, neurodegenerative disorders, heart 
disease, and infection [5–8]. miRNAs play a substantial 
role in the regulatory gene expression process and it is 
estimated that about one-third of the human genome 
transcriptome being regulated by actions of miRNAs [9]. 
miRNAs influence gene regulation of essential biologi-
cal pathways such as cellular development, proliferation, 
apoptosis, and cellular signaling [5, 10]. From its intra-
cellular origin, miRNA can be secreted extracellularly 
bound to AGO2 [10], or secreted in cell-derived extracel-
lular vesicles/exosomes and serve as personalized signa-
tures reflecting the disease status or perform cell-to-cell 
communication [11].
Differential expression signatures of miRNAs associ-
ated with different diseases have been evaluated mostly 
in whole plasma and serum [12, 13]. However, it can 
be difficult to interpret the result of disease-specific 
miRNA biomarkers in healthy and diseased patients due 
to genetic material instability stemming from RNases, 
sample variation, normalization, and nonspecific acti-
vated pathways in various diseases [14]. With the intro-
duction of EVs as an enriched source of miRNAs, new 
horizons opened in biomarker discovery based on EVs 
[15]. EVs are a mixed population of heterogeneous mem-
branous vesicles shedding from cells in both physiologi-
cal and pathological states. Their sizes range from 50 nm 
in diameter and up to 1,000 nm [10]. Exosomes are the 
smallest subpopulation of EVs originating from multive-
sicular bodies and can be isolated from different biofluids 
using standardized protocols. Exosomes can act as stable 
reservoirs of biomarkers in different diseases by contain-
ing genetic materials that reflect the disease stage [16].
A great proportion of circulating miRNA is associated 
with exosomes. Exosome associated miRNA is reported 
to be more stable and resistant to RNase enzymatic activ-
ity compared to non-exosome associated miRNAs [17, 
18]. Although there is some evidence indicating deregu-
lation of miRNAs in different liver diseases [19, 20], there 
is no study regarding the biomarker value of exosome-
associated miRNAs in AH. The aim of the present study 
was to assess the utility of exosome-associated miRNAs 
as potential biomarkers for AH. In the present study, 
we demonstrate that miRNAs in circulation are largely 
encapsulated in exosomes and carry a specific signa-
ture after alcohol induced liver injury in chronic alcohol 
fed mice and patients with AH. We used chronic alco-
hol feeding in a mouse model and found a specific sig-
nature of miRNA associated with liver injury. Next, we 
validated our results in a cohort of human subjects with 
AH. Our results indicate that exosomes transport alcohol 
induced liver injury-specific molecular information in 
the circulation.
Methods
Human studies
Confirmed cases of alcoholic hepatitis (n  =  14) and 
healthy individuals (n =  10) were enrolled in the study. 
The diagnosis of alcoholic hepatitis was established 
by expert clinicians based on medical history, physi-
cal examination and laboratory data according to the 
guidelines of the American College of Gastroenterology 
[21]. In cases of uncertain diagnosis, liver biopsy was 
obtained. Patients were included from different stages 
of alcoholic hepatitis. Healthy individuals were defined 
as being free of any systemic and non-systemic diseases 
based on patients’ history and routine laboratory findings 
identified by primary care physician. These individuals 
provided history of “only social” alcohol consumption. 
Both controls and patients were enrolled consecutively 
to study to avoid selection bias. The study protocol was 
approved by Institutional Review Board for the Protec-
tion of Human Subjects in research at the University of 
Massachusetts Medical School (Worcester, MA, USA). 
Written informed consents were obtained from all 
subjects.
Animal studies
6 to 8-week-old female C57BL/6 mice were purchased 
from Jackson Laboratory. The animal study protocol 
was approved and conducted according to the regula-
tions of the Institutional Animal Care and Use Commit-
tee (IACUC) of the University of Massachusetts Medical 
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School (Worcester, MA, USA). In the alcohol experimen-
tal group (n = 12), mice received 5% (v/v) ethanol (36% 
ethanol-derived calories) containing Lieber–DeCarli 
diet (EtOH) for 4  weeks. The matched pair-fed animals 
received (n  =  12) an isocaloric alcohol-free diet (pair-
fed) to ensure equal nutrient and calorie intake between 
groups. Mice were euthanized at the end of experimen-
tal time course and serum was separated from the whole 
blood and the livers were collected. Serum ALT was 
measured using a kinetic method (D-Tek LLC).
For histopathological analysis, sections of formalin-
fixed livers were stained with hematoxylin–eosin to study 
for steatosis, necrosis and inflammation. Flowcytometry 
was performed to study the immune cell population in 
the liver of the pair fed and ethanol fed mice as previ-
ously described [22].
Exosomes isolation
For exosome isolation from sera of mice and plasma of 
human subjects, exosomes were isolated from 150  µl of 
sera or plasma following the previously established pro-
tocol [17]. Briefly, the serum or plasma were centrifuged 
at 1,500×g for 5  min to remove cells and 10,000×g for 
20 min to remove residual cellular debris. Samples were 
serially filtered through 0.8, 0.44  μm (Millipore, Bill-
erica, MA, USA). The filtered supernatant was used to 
precipitate exosomes with Exoquick-TC™ (according to 
the manufacturer’s guidelines). Exosome pellet was re-
suspended in PBS. For isolating smaller subpopulation 
of exosomes (diameter <200 nm) we added an additional 
step before re-suspension in PBS and filtered the samples 
with 0.2 µm filters.
Nanoparticle Tracking Analysis (NTA)
The concentration and size range of circulating EVs in 
human subjects and mice were identified by a NanoSight 
NS300 system (NanoSight, Amesbury, UK) supplied with 
a fast video capture and Nanoparticle Tracking Analy-
sis (NTA) software. Before performing the experiments, 
the instrument was calibrated with 100  nm polystyrene 
beads (Thermo Scientific, Fremont, CA, USA). The sam-
ples were captured for 60  s at room temperature. NTA 
software processed the video captures and measured the 
concentration of the particles (particles/ml) and size dis-
tribution (in nanometer). Each specimen was measured 
three times.
Electron microscopy
Isolated EVs from plasma and serum were re-suspended 
in PBS and placed on a formvar-coated copper grid and 
then allowed to settle for 45 min. Sequential PBS wash-
ing of the grid was done by positioning droplets of PBS 
on the top and applying absorbing paper in between. 
The samples were fixed by positioning the grid on the 
top of 2% paraformaldehyde placed on the parafilm for 
15 min. After fixation and three washing steps, samples 
were contrasted by adding drops of 2% uranyl acetate for 
15 min. A drop of 0.13% methyl cellulose and 0.4% uranyl 
acetate was placed on the parafilm grid was incubated at 
the top for 10 min. The grid was visualized by a Philips 
CM10 transmission electron microscope and images 
were recorded using a Gatan CCD digital camera.
Western blotting
After isolating exosomes from mice sera, presence of 
CD63 and GRP78 were determined with western blot, 
using our laboratory’s established protocol. Briefly, 
exosomes were lysed in RIPA buffer and run on a 15% 
polyacrylamide gel. Proteins were transferred to nitro-
cellulose membrane overnight then blocked for 3  h in 
blocking buffer (1× TBST with 5% w/v nonfat dry milk). 
Primary antibody against CD63 and GRP78 (Abcam, 
Cambridge, MA, USA) was used overnight at 4°C at 
1:2,000 dilution in the blocking buffer. For detection, 
secondary goat anti-mouse HRP-linked antibody (Santa 
Cruz Biotechnology, Dallas, TX, USA) was used for 1 h 
at a dilution rate of 1:5,000 in blocking. The immunore-
active bands were visualized by a Clarity™ Western ECL 
substrate kit (BioRad) according to the manufacturer’s 
protocol and LAS-4000IR Ver.2.02 (Fujifilm, Valhalla, 
NY, USA). Mouse primary hepatocytes were used as neg-
ative control.
RNA isolation
Isolated EVs from 150  μl of mice sera and patients’ 
plasma were lysed in 500 and 1,000  µl of QIAzol Lysis 
reagent, respectively. Total RNA was extracted using 
Direct-zol™ RNA MiniPrep isolation kit (Zymo Research 
Corp, Irvine, CA, USA). The standard manufacturer’s 
protocol was followed, and extracted RNA was eluted 
with 25 μl of RNase-free water. The RNA was quantified 
using and NanoDrop 1000 and the quality of RNA was 
assessed by 260/280 and 260/230 ratios.
Microarray analysis
In addition, the Firefly miRNA multiplex assay (Firefly™ 
bioworks, Cambridge, MA, USA) was used to profile EV-
associated miRNA isolated from mice sera for a targeted 
list of 68 miRNAs. Total RNA (12 μl) was assayed by the 
Firefly standard protocol and analyzed with a Millipore 
Guava 8HT flow cytometer.
Data processing, analysis, and visualizations were per-
formed using Firefly™ Analysis Workbench. The software 
was used to compare data quality with historical values, 
perform image processing, normalization, and trans-
formation. Raw probe intensities were analyzed using 
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Wilcoxon’s signed rank test. Signal intensities were trans-
formed to log ratio for each probe on the alcohol group 
array to the counter parting probe pair on the control 
array. miRNA-15b was used for normalizing array data. 
Signal log ratio was computed by using a t test. After gen-
erating a list of differentially expressed miRNAs, down-
stream analysis was performed. The identified miRNA 
were clustered in by K mean clustering and heat-map 
generated. The targets of miRNA-192 and miRNA-30a 
target were visualized using Cytoscape V2.7. miRDB, 
miRanda, and mirSVR databases were used for miRNAs 
target predictions.
miRNA analysis
We used TaqMan® miRNA Assays (Applied Biosystems, 
Catalog number: 4366597) for confirmation of microar-
ray and evaluating the expression level of miRNA-122 
(Applied Biosystems, Catalog number: A25576), miRNA-
30a (Applied Biosystems, Catalog number: 4427975) 
and miRNA-192 (Applied Biosystems, Catalog number: 
A25576). Reverse transcription was performed using 
a TaqMan stem loop primer, TaqMan primers, 10  ng 
RNA, and miRNA reverse transcription kit in an Eppen-
dorf Realplex Mastercycler (Eppendorf, Westbury, NY). 
The cycle was as follows: 30  min, 16°C; 30  min, 42°C; 
5  min 85°C. The cDNA was mixed with TaqMan® Uni-
versal PCR Master and quantitative real-time PCR was 
performed using a Bio-Rad CFX96 iCycler device. Syn-
thetic C. elegans-miRNA-39 was spiked as external con-
trol during the total RNA isolation from human plasma 
samples. Consistent with the array findings, miRNA-15b 
was used for normalization of mice sera in confirmatory 
qPCR analysis. The amplification efficiency of qPCR was 
verified in our lab and it was very close to 100%. Samples 
were processed in duplicate and the relative expression 
level of specific miRNA calculated by 2−ΔΔCt method. 
NormFinder was used to identify the suitable endoge-
nous normalizer [23].
Statistical analysis
Data are expressed as mean ±  standard error (SE). For 
pair-wise comparisons, non-parametric Mann–Whitney 
test or parametric t-test were used based on underly-
ing distribution. The ability to discriminate between the 
alcohol fed mice/alcoholic hepatitis patients and control 
groups was evaluated by the receiver operating charac-
teristic curve, and the area under the curve (AUC) was 
calculated as a measure of test accuracy. For group-wise 
comparison, Kruskal–Wallis non parametric test or 
ANOVA parametric test were used and a p ≤  0.05 was 
considered as statistically significant. Correlation of ALT 
with exosome numbers was identified by Spearman cor-
relation test. For statistical analysis and heat map data 
visualization, GraphPad Prism v.4.03 (GraphPad Soft-
ware Inc.) and Firefly™ Analysis Workbench software 
were used, respectively.
Results
Total number of EVs is increased in alcohol‑fed mice 
compared to the pair‑fed mice
The total number of EVs was significantly increased in 
mice sera after chronic alcohol feeding compared to pair-
fed controls (p < 0.05), measured by NanoSight (Fig. 1a). 
Most of the EVs had a smaller diameter and were in the 
size of exosomes subfraction of EVs compared to the 
larger size microvesicles sub-fraction. Serum ALT levels 
were significantly increased after 4 weeks of alcohol feed-
ing indicting alcohol-induced liver damage, as seen before 
in chronically alcohol-fed mice compared to the paired-
fed controls (Fig. 1b) [24]. EVs isolated from alcohol-fed 
mice demonstrated the previously described morphol-
ogy of EVs on electron micrograph [25], and expressed 
the exosomal marker CD63 (Fig.  1c, d). Loading of the 
same amounts of input proteins, exosomes isolated from 
sera of alcohol-fed mice and pair-fed mice showed similar 
amount of CD63 while primary hepatocytes showed less 
expression of CD63. GRP78, the intracellular endoplasmic 
reticulum marker, was present in primary hepatocytes 
while it was absent in the exosomes (Fig. 1d). Size distri-
bution of the EVs in mice sera in both alcohol-fed mice 
and pair-fed mice indicated an abundance of smaller vesi-
cles in the range of 50–150 nm supporting predominance 
of exosomes (Fig.  1e). Exosomes were isolated based on 
combination of serial filtration and precipitation reagent 
(ExoQuick). Quantitative measurement of particles with 
Nanoparticle Tracking Analysis (NTA) showed no signifi-
cant difference in the distribution of EVs in crude serum 
and exosomes after isolation (data not shown). We used 
a 4-week Lieber–Decarli diet model for alcohol induced 
liver injury in mice which is an established model result-
ing in mild alcoholic steatohepatitis [26]. The histological 
and molecular changes confirmed liver injury, steatosis 
and inflammation in the Lieber Decarli model compared 
to pair-fed mice are shown in Additional file  1: Figure 
S1. Salient features included steatosis, macrophage/KC 
infiltration and activation, neutrophils activation and 
increased pro-inflammatory cytokines in the livers of 
alcohol-fed mice (Additional file 1: Figure S1).
Correlation of ALT with exosome number
Exosome number (particles/ml) showed a strong and sta-
tistically significant correlation with ALT levels (IU/L) 
(Spearman’s Rho, r = 0.80) (p < 0.05) (Fig. 2a). Interest-
ingly, a great portion of total serum RNA were packed 
within the serum-exosomes compared to the exosome 
depleted serum (Fig. 2b).
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Introducing endogenous control normalizer in EVs isolated 
from mice sera
Next, liver miRNA microarray was performed on exo-
some-associated miRNA, using The Firefly™ microRNA 
Assay which includes miRNA signatures of 68 miRNAs 
associated with liver inflammatory pathways. First to 
ensure reproducibility and reliability, spiked positive 
control values were compared with historical value iden-
tified for the same amount of miRNAs. The spiked posi-
tive controls showed excellent correlation with historical 
values (p = 0.98) (Fig. 2c). This was a quality control step 
to evaluate the ability of the assay to distinguish differ-
ent value of spiked positive control. Our results indi-
cated that assay readouts were sensitive to the amount of 
miRNA and increase linearly when the amount of spiked 
in control increased. Of the 68 miRNAs indicated in the 
inflammatory panel, 63 miRNAs were detectable in our 
samples (Fig. 2d).
Lack of suitable endogenous control normalizer has 
been one of the main limitations of using miRNA and 
EVs associated miRNA diagnostics. Regarding the suit-
able endogenous control normalizer, miRNA-15b, 
miRNA-20a and miRNA-15b expression levels showed 
the lowest intragroup and intergroup variability, with the 
stability value of 0.189 and 0.232 respectively, accord-
ing to NormFinder algorithm (Table  1). In RT-qPCR 
analysis, miRNA-15b consistently showed minimal 
variability in expression levels among different group of 
experiments.
Differential miRNA signature of alcohol‑fed mice 
versus control mice
Exosomes were isolated from the sera of 12 chronic 
alcohol-fed mice and 12 pair-fed mice. To obtain enough 
exosome-associated total RNA for running microarrays 
and subsequent qPCR validation, we pooled two samples 
Fig. 1 Extracellular vesicles (EVs)/exosomes characterization and enumeration and serum ALT levels. a Total number of EVs in the sera of chronic 
alcohol‑fed mice and pair‑fed mice were measured by a Nanoparticle Tracking analysis (Nanosight). b Serum ALT (IU/L) levels were measured in 
pair‑fed mice and alcohol‑fed mice. c Transmission electron micrographs of exosomes isolated from alcohol‑fed mice showed diameters less than 
150 nm. d Same amount of protein loaded into the all columns. Isolated exosomes from sera of alcohol‑fed mice (Et‑exo) and pair‑fed mice (PF‑exo) 
expressed CD63. GRP78 was detectable only in primary hepatocytes (Hepa). e The average size of exosomes was measured by Nanoparticle Track‑
ing analysis (NTA).
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randomly for a total of six samples in each control and 
alcohol-fed group. In two samples from the alcohol-fed 
pair-fed groups, respectively, we isolated the smaller sub-
population of exosomes with the diameter of less than 
200  nm, to compare the differential signature between 
the whole population of exosomes and smaller subpopu-
lation of exosomes. miRNA analysis of microarray data 
showed no significant difference in miRNA signature 
between total exosomes and smaller subpopulation of 
exosomes (with diameter less than 200 nm) in mice sera 
(Fig. 3). This is in accordance with our previous findings 
regarding the presence of homogenous exosomes in mice 
sera [27].
The heat map and the list of deregulated miRNAs 
in EVs isolated from alcohol-fed and pair-fed mice are 
shown in Fig.  3 and Table  2 respectively. Confirmatory 
qPCR using miRNA-15b as endogenous normalizer and 
identical amount of exosomal RNA input, showed that 
miRNA-192, miRNA-122, and miRNA-30a levels in EVs 
isolated from sera of alcohol-fed mice were significantly 
increased in alcohol-fed mice compared to the control 
pair-fed mice (Fig.  4a). In addition, miRNA-744 (1.49-
fold), miRNA-1246 (2.40-fold), miRNA-30b (1.50-fold) 
demonstrated a significant increases in alcohol-fed mice 
compared to the pair-fed mice (p < 0.05).
miRNA‑192, miRNA‑122 and miRNA‑30a accurately 
discriminate the alcohol‑fed and control mice
Consistent with the highly significant increase of miRNA-
122, miRNA-30a, and miRNA-192 (Fig.  4a–c), those 
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miRNAs showed promising diagnostic values. To test the 
diagnostic value of the identified miRNAs, we performed 
Receiver–Operator Characteristic (ROC) curves analysis, 
and we found that miR-192 has the highest area under 
the curve (AUC  =  0.96; p  <  0.001). miRNA-122 and 
miRNA-30a showed an AUC of 0.92 (p < 0.001) and 0.85 
(p < 0.05), respectively (Table 3; Fig. 4d–f).
Increased number of EVs in plasma of alcoholic hepatitis 
patients and characteristic miRNA profile of EVs
We evaluated the number and profile of EVs in patients’ 
plasma (n =  14) and found a significant increase in the 
number of EVs in the plasma of patients with alcoholic 
hepatitis, compared to healthy controls (Fig.  5a). The 
mean age for patients with alcoholic hepatitis and con-
trol subjects were 46.28 (SD 6.43) and 28.9 (SD 3.03), 
respectively. The baseline characteristics of patients 
are shown in the Additional file  1: Table S1. Consistent 
with the animal study, most of the circulating EVs in 
plasma of alcoholic hepatitis patients were in the range 
Table 1 Stability values of different miRNAs based on Nor-
mFinder
Gene name Stability value Norm Finder ranking
miRNA‑15b 0.189 1
miRNA‑20a 0.321 3
miRNA‑29a 0.405 4
Best combination of two genes
 miRNA‑20a and miRNA‑15b 0.232 2
Group identifier EVs isolated from  
ethanol‑fed mice
EVs isolated from  
pair‑fed mice
Intra‑group variation
 miRNA‑15b 0.101 0.092
 miRNA‑20a 0.231 0.412
 miRNA‑29a 0.321 0.249
Intergroup variation
 miRNA‑15b 0.003 0.007
 miRNA‑20a 0.201 0.310
 miRNA‑29a 0.241 0.379
Fig. 3 Heat map of differentially expressed EV‑associated miRNAs in alcohol‑fed mice versus pair‑fed mice. Heat map of differentially expressed 
miRNAs in exosomes isolated from alcohol‑fed mice (alcohol exosomes) compared to exosomes isolated from pair‑fed mice (control exosomes) 
using Firefly biowork miRNA assay.
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of exosomes (less than 150  nm) (Fig.  5a). The level of 
miRNA-30a and miRNA-192 showed elevated levels in 
exosomes in patients with alcoholic hepatitis compared 
to healthy controls (Fig.  5b, c). miRNA-122 showed 
elevated levels in exosomes isolated from patients with 
alcoholic hepatitis, but it did not reach statistical signifi-
cance (Fig. 5d). Based on ROC curve analysis, exosome-
associated miRNA-192 can act as an accurate diagnostic 
test for discrimination of liver disease in the population 
(AUC = 0.95; p < 0.001) (Fig. 5e, f; Table 3). Using target 
prediction algorithms, we identified the predicted target 
protein networks of human miRNA-192 and miRNA-
30a (Fig.  6a, b). The first thirty ranked target genes of 
miRNA-192 and miRNA-30a, as well as gene description 
are shown in Additional file 1: Tables 2 and 3.
Discussion
Extracellular vesicles, including microvesicles, exosomes 
and apoptotic bodies are released from almost all cell 
types into the microenvironment, and involved in physi-
ological function and the pathology of different diseases 
[28]. In this study, we found a significantly increased 
number of circulating EVs in sera of alcohol-fed mice 
compared to pair-fed mice. Similarly, we observed a 
significantly increased number of EVs in plasma of AH 
patients, compared to healthy controls. Interestingly, the 
vesicles in both animal model and human subjects were 
Table 2 Differential miRNA signature of  extracellular-ves-
icles derived from  sera of  chronic alcohol-fed mice com-
pared to the pair-fed mice
* P‑value obtained from t‑test.
Probes Fold changes P value*
Increased miRNAs in alcohol‑fed mice EVs vs paired‑fed mice EVs
 miRNA‑192 3.29 <0.001
 miRNA‑122 4.78 0.001
 miRNA‑30a 1.96 0.001
 miRNA‑744 1.53 0.009
 miRNA‑1246 2.90 0.037
 miRNA‑30b 1.66 0.040
 miRNA‑130a 1.85 0.042
Decreased miRNAs in alcohol‑fed mice EVs vs paired‑fed mice EVs
 miRNA‑132 1.44 0.012
 miRNA‑494 1.16 0.011
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Graph demonstrating confirmatory TaqMan miRNA qPCR assay for quantification of a miRNA‑122, b miRNA‑192 and c miRNA‑30 levels in serum‑
derived exosome isolated from alcohol‑fed mice compared to pair‑fed mice. Curve of receiver operating characteristic (ROC) analysis constructed 
using differentially expressed d miRNA‑122, e miRNA‑192, and f miRNA‑30a for discriminating alcohol‑fed mice versus control mice.
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mostly in the size range of exosomes; the smaller sub-
population of vesicles. Although there are a few reports 
that address the roles of EVs in various liver diseases [27, 
29–31], this is the first report regarding increased num-
bers of EVs in alcoholic hepatitis patients.
We found a strong linear correlation between exosome 
numbers and ALT levels, indicating that the exosomes 
machinery is affected and an increase in exosome num-
bers mirrors the hepatocellular damage induced by 
ethanol. Exosomes originate specifically from secretory 
multivesicular endosome bodies (MVBs). It has been 
shown that exosome biogenesis can be ESCRT-complex 
dependent or sphingomyelinase dependent. Tetraspa-
nins, which are highly enriched in the MVBs, have often 
been associated with exosomes; smaller sub-fraction of 
EVs [32, 33]. In this study we observed an increased num-
ber of exosomes in the plasma of patients with alcoholic 
hepatitis and sera of mice after chronic alcohol feed-
ing, which indicate the activation of exosome biogenesis 
pathways. The fact that we did not observe a considerable 
amount of microvesicles in models may indicate that the 
ethanol exposure induces cell stress below the threshold 
stress for inducing cell death [34]. From the evolution-
ary biology point of view, increased amount of exosomes 
shedding after alcohol assault may indicate evolutionary 
plasticity of the cells for limiting the stressor constrain.
While the mechanism of the EVs biogenesis var-
ies in different subpopulations, genetic materials were 
detected in all type of vesicles [35]. Analysis of genetic 
material secreted within different subpopulation of EVs 
in circulation represents a unique opportunity for diag-
nosis and therapeutic monitoring of alcoholic hepatitis. 
Recent evidence suggests that circulating miRNAs can 
exist in two distinct forms: (1) as free floating EVs where 
they form a complex with Argonaute 2, the RNA induced 
silencing complex (RISC), or high density lipoproteins 
Table 3 ROC curve analysis indicating diagnostic value 
of each miRNA
AUC (area under  
the curve)
Standard  
error
P value
EVs from alcohol‑fed mice vs paired‑fed mice
 miRNA‑122 0.9260 0.05487 P < 0.001
 miRNA‑192 0.9668 0.03007 P < 0.001
 miRNA‑30a 0.8532 0.08031 P < 0.05
EVs from alcoholic hepatitis patients vs control individuals
 miRNA‑192 0.95 0.8–1 p < 0.001
 miRNA‑30a 0.58 0.1589 P = 0.56
Fig. 5 EVs/exosomes characterization and signature in patients with alcoholic hepatitis (AH) versus controls and receiver operating characteris‑
tic (ROC) curves. a Number of EVs was measured in the plasma of patients with alcoholic hepatitis and healthy individuals using a Nanoparticle 
tracking analysis (Nanosight). The EVs with diameters less than 150 nm were defined as exosomes and EVs with diameter more than 150 nm were 
defined as microvesicles. b–d Levels of miRNA‑122, miRNA‑192 and miRNA‑30 were quantified in plasma‑derived EVs isolated from alcoholic hepa‑
titis individuals and healthy controls by TaqMan qPCR assay. e, f Curve of receiver operating characteristic (ROC) analysis constructed for differen‑
tially expressed miRNA‑30a, miRNA‑192, and for discriminating patients with alcoholic hepatitis versus controls (*p < 0.05).
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Fig. 6 Target prediction for miRNA‑30a and miRNA‑192. a Potential targets of miRNA‑30a. b Potential targets of miRNA‑192.
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and (2) as packaged within the EVs/exosomes [36, 37]. 
We found that total RNA is more abundant in the exo-
some fraction compared to the non-exosome fraction. 
Exosome-based diagnosis confers several advantages for 
biomarker discovery compared to conventional strat-
egies involving whole blood analysis. First, exosomes 
contain RNA, lipids, and proteins that are reflective of 
the status of parental cells and disease-specific protein 
or RNA, which are often detected in exosomes [35–37]. 
Second, the contents inside exosomes are protected by a 
lipid bilayer of exosomes, which leads to better stability 
of bio-macromolecules. Third, exosomes are very stable 
and can be stored for extended period of time. Fourth, 
exosome-based analysis reduces the complexity of bioflu-
ids thereby aiding in the more specific and more sensitive 
detection of low abundance bio-macromolecules [15, 38, 
39]. Although different exosome isolation methods may 
yield varying results, using a validated established proto-
col for isolation demonstrates great reproducibility. We 
used a combination of serial filtration and ExoQuick for 
isolation of exosomes which has shown reproducibility 
and efficiency for quantitative studies [40].
We found nine deregulated inflammatory miRNAs in 
exosomes of alcohol-fed mice. Particularly, miRNA-122, 
miRNA-30a, and miRNA-192 showed the most substan-
tial increases and revealed an excellent diagnostic value 
for differentiating alcohol-fed mice versus pair-fed mice. 
Importantly, of these miRNAs in the cohort of patients 
with alcoholic hepatitis, we found a significantly elevated 
level of miRNA-30a and miRNA-192 in the EV-fraction 
of plasma. This observation in human AH validated 
our findings in the animal model and indicates that the 
chronic Lieber DeCarli ethanol feeding model par-
tially presents similar features of human AH. We found 
elevated levels of miRNA-122 in the circulation in the 
Lieber–DeCarli dietary mouse model. In contrast, we did 
not observe statistically significant elevation in miRNA-
122 in exosomes isolated from sera of patients with alco-
holic hepatitis, which may indicate the difference of the 
Lieber DeCarli alcohol model with alcoholic hepatitis in 
patients. This result might be attributed to the patients’ 
heterogeneity in terms of being in different stages of alco-
holic hepatitis or having different kinetics of miRNA-122 
in alcohol-induced liver injury.
miRNA-192 showed consistently elevated levels in both 
alcohol-fed mice samples and in patient- derived alco-
holic hepatitis samples. miRNA-192 is the second most 
abundant miRNA in the human liver and considered 
as one of the liver specific miRNA constituting around 
16.9% of the miRNome in normal liver tissue [41]. In 
spite of the high abundance in the liver, its regulation 
in the liver is tightly controlled and was not changed 
in hepatocellular carcinoma and viral hepatitis [41]. 
In a study done by our group [42], we showed differen-
tial distribution of miRNAs in exosomes and exosome-
depleted serum fraction in different types of liver injury. 
In particular, in alcoholic hepatitis and in inflammatory 
liver injury, serum/plasma miRNA-122 and miRNA-155 
were predominantly associated with the exosome-rich 
fraction.
We showed that miRNA-192 levels can be used to dif-
ferentiate plasma from alcoholic hepatitis patients and 
plasma from controls. Importantly, our results were 
validated on plasma samples from several individuals. 
Interactome analysis of miRNA-192 revealed activation 
of Smad signaling and ZEB proteins, which are related 
to alcoholic hepatitis pathobiology through regulation 
of TGFβ/Smad signaling [43]. Another target of miRNA-
192 that showed overlap with known pathways of alco-
holic hepatitis is Jak2/Arhgef1 signaling pathway, which 
is correlated with severity of liver disease [44].
The finding of elevated levels of miRNAs species in 
exosomes after alcohol administration from other tissues 
such as miRNA-30a, which is highly expressed in heart 
cells [45], may further demonstrate the effect of alcohol 
on multiple organs and cell types despite the majority of 
pathological damage being reported as confined to the 
liver. Indeed, chronic alcohol administration is associated 
with direct cardiomyopathy and anemia-induced cardio-
myopathy, both in humans and animal models [46, 47]. 
The diverse origin of exosome-associated miRNAs also 
suggests that using circulating miRNA as a specific win-
dow into the physiopathological condition of the whole 
effects of alcohol, perhaps in concert with certain other 
markers profile, will be a powerful approach for diagno-
sis. However, more data regarding specificity of miRNA-
192 and miRNA-30a for alcoholic hepatitis compared to 
the other types of liver disease, and side by side compari-
son of those miRNA markers with other markers of liver 
injury such as ALT should be gathered in future studies. 
Although we found significant discriminatory ability of 
exosomal miRNA-192 for alcoholic hepatitis, our study is 
in the discovery phase and has limited sample size. Fur-
ther investigations are warranted to confirm our findings 
in larger cohorts of patients and comparing miR-192 with 
established scores such as MELD and Maddrey scores.
Conclusions
In this study we showed that the total number of circulat-
ing extracellular vesicles is significantly increased in alco-
hol-fed mice and human subjects with alcoholic hepatitis. 
Those EVs were in the range of smaller sub-population of 
EVs, called exosomes. Comparing the miRNA signature 
of exosomes from alcohol-fed mice with pair-fed mice 
showed deregulation of nine inflammatory miRNAs 
including miRNA-122, miRNA-192 and miRNA-30a. 
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Of those, three miRNA were significantly up-regulated 
in alcohol-fed mice compared to pair-fed mice and had 
valuable diagnostic values. Consistently, miRNA-30a and 
miRNA-192 were increased significantly in exosomes 
isolated from plasma of alcoholic hepatitis patients.
Authors’ contributions
Conceived and designed the experiments: FMH, BS, GS; Performed the experi‑
ments: FMH, BS KK, DC, AS; Analyzed and interpreted the data: FMH, BS, GS; 
Contributed reagents/materials/analysis tools: GS; Wrote the paper: FMH and 
GS. All authors read and approved the final manuscript.
Acknowledgements
This study was supported by Grants: AA021907, AA021893, and AA011576 to 
GS.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 1 May 2015   Accepted: 29 July 2015
References
 1. Orman ES, Odena G, Bataller R (2013) Alcoholic liver disease: pathogen‑
esis, management, and novel targets for therapy. J Gastroenterol Hepatol 
28(Suppl 1):77–84
 2. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state 
of serum biomarkers of hepatotoxicity. Toxicology 245:194–205
 3. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008) Serum 
activity of alanine aminotransferase (ALT) as an indicator of health and 
disease. Hepatology 47:1363–1370
 4. Iorio MV, Croce CM (2009) MicroRNAs in cancer. J Clin Oncol 
27:5848–5856
 5. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J 
Pathol 223:102–115
 6. Momen‑Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS (2014) Genom‑
ewide study of salivary microRNAs for detection of oral cancer. J Dent Res 
93:86S–93S
 7. Akat KM, Moore‑McGriff D, Morozov P, Brown M, Gogakos T, Correa Da 
Rosa J et al (2014) Comparative RNA‑sequencing analysis of myocardial 
and circulating small RNAs in human heart failure and their utility as 
biomarkers. Proc Natl Acad Sci USA 111:11151–11156
 8. Bekris LM, Leverenz JB (2015) The biomarker and therapeutic potential of 
miRNA in Alzheimer’s disease. Neurodegener Dis Manag 5:61–74
 9. How CK, Hou SK, Shih HC, Huang MS, Chiou SH, Lee CH et al (2015) 
Expression profile of microRNAs in gram‑negative bacterial sepsis. Shock 
43:121–127
 10. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene 
regulation. Nat Rev Genet 5:522–531
 11. Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O (2012) Selec‑
tive autophagy degrades DICER and AGO2 and regulates miRNA activity. 
Nat Cell Biol 14:1314–1321
 12. Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A et al 
(2014) Quantification and size‑profiling of extracellular vesicles using 
tunable resistive pulse sensing. J Vis Exp 92:e51623
Additional file
Additional file 1: Figure S1. Histological and molecular changes in 
Lieber‑DeCarli mice model. Table S1. Characteristics of patients with 
alcoholic hepatitis. Table S2. Predicted targets of miRNA‑192. Table S3. 
Predicted targets of miRNA‑30a.
 13. Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S et al (2014) 
A pilot study to develop a diagnostic test for pancreatic ductal adenocar‑
cinoma based on differential expression of select miRNA in plasma and 
bile. Am J Gastroenterol 109:1942–1952
 14. Sheinerman KS, Umansky SR (2013) Circulating cell‑free microRNA as 
biomarkers for screening, diagnosis and monitoring of neurodegenera‑
tive diseases and other neurologic pathologies. Front Cell Neurosci 7:150
 15. Jia S, Zocco D, Samuels ML, Chou MF, Chammas R, Skog J et al (2014) 
Emerging technologies in extracellular vesicle‑based molecular diagnos‑
tics. Exp Rev Mol Diagn 14:307–321
 16. Momen‑Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog 
J et al (2012) Impact of biofluid viscosity on size and sedimentation 
efficiency of the isolated microvesicles. Front Physiol 3:162
 17. Momen‑Heravi F, Bala S, Bukong T, Szabo G (2014) Exosome‑mediated 
delivery of functionally active miRNA‑155 inhibitor to macrophages. 
Nanomedicine 10:1517–1527
 18. Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a pro‑
tective and enriched source of miRNA for biomarker profiling compared 
to intracellular and cell‑free blood. J Extracell Vesicles 3:10
 19. Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A et al 
(2014) Circulating extracellular vesicles with specific proteome and liver 
microRNAs are potential biomarkers for liver injury in experimental fatty 
liver disease. PLoS One 9:e113651
 20. Arrese M, Eguchi A, Feldstein AE (2015) Circulating microRNAs: emerging 
biomarkers of liver disease. Semin Liver Dis 35:43–54
 21. O’Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of 
the American Association for the Study of Liver Diseases, Practice Param‑
eters Committee of the American College of Gastroenterology (2010) 
Alcoholic liver disease. Hepatology 51:307–328
 22. Petrasek J, Iracheta‑Vellve A, Saha B, Satishchandran A, Kodys K, Fitzgerald 
KA et al (2015) Metabolic danger signals, uric acid and ATP, mediate 
inflammatory cross‑talk between hepatocytes and immune cells in 
alcoholic liver disease. J Leukoc Biol 98:249–256
 23. Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of real‑time 
quantitative reverse transcription‑PCR data: a model‑based variance 
estimation approach to identify genes suited for normalization, applied 
to bladder and colon cancer data sets. Cancer Res 64:5245–5250
 24. Nath B, Levin I, Csak T, Petrasek J, Mueller C, Kodys K et al (2011) 
Hepatocyte‑specific hypoxia‑inducible factor‑1α is a determinant of 
lipid accumulation and liver injury in alcohol‑induced steatosis in mice. 
Hepatology 53:1526–1537
 25. Momen‑Heravi F, Balaj L, Alian S, Tigges J, Toxavidis V, Ericsson M et al 
(2012) Alternative methods for characterization of extracellular vesicles. 
Front Physiol 3:354
 26. Leung TM, Lu Y, Yan W, Morón‑Concepción JA, Ward SC, Ge X et al (2012) 
Argininosuccinate synthase conditions the response to acute and 
chronic ethanol‑induced liver injury in mice. Hepatology 55:1596–1609
 27. Momen Heravi F, Bala S, Kodys K, Szabo G (2015) Exosomes derived from 
alcohol‑treated hepatocytes horizontally transfer liver specific miRNA‑122 
and sensitize monocytes to LPS. Sci Rep 5:9991
 28. Momen‑Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, Trachtenberg AJ 
et al (2013) Current methods for the isolation of extracellular vesicles. Biol 
Chem 394:1253–1262
 29. Bukong TN, Momen‑Heravi F, Kodys K, Bala S, Szabo G (2014) Exosomes 
from hepatitis C infected patients transmit HCV infection and contain 
replication competent viral RNA in complex with Ago2‑miR122‑HSP90. 
PLoS Pathog 10:e1004424
 30. Masyuk AI, Masyuk TV, Larusso NF (2013) Exosomes in the pathogenesis, 
diagnostics and therapeutics of liver diseases. J Hepatol 59:621–625
 31. Rodríguez‑Suárez E, Gonzalez E, Hughes C, Conde‑Vancells J, Rudella 
A, Royo F et al (2014) Quantitative proteomic analysis of hepatocyte‑
secreted extracellular vesicles reveals candidate markers for liver toxicity. 
J Proteom 103:227–240
 32. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, 
microvesicles, and friends. J Cell Biol 200:373–383
 33. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F et al 
(2008) Ceramide triggers budding of exosome vesicles into multivesicular 
endosomes. Science 319:1244–1247
 34. Théry C, Boussac M, Véron P, Ricciardi‑Castagnoli P, Raposo G, Garin J et al 
(2001) Proteomic analysis of dendritic cell‑derived exosomes: a secreted 
Page 13 of 13Momen‑Heravi et al. J Transl Med  (2015) 13:261 
subcellular compartment distinct from apoptotic vesicles. J Immunol 
166:7309–7318
 35. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S et al (2013) 
miR‑21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a 
platform for glioblastoma biomarker development. PLoS One 8:e78115
 36. Fujita Y, Kuwano K, Ochiya T, Takeshita F (2014) The impact of extracel‑
lular vesicle‑encapsulated circulating microRNAs in lung cancer research. 
Biomed Res Int 2014:486413
 37. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization 
of extracellular circulating microRNA. Nucleic Acids Res 39:7223–7233
 38. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles 
important in intercellular communication. J Proteom 73:1907–1920
 39. Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly 
stable resource of disease biomarkers. Proteom Clin Appl 9:358–367
 40. Caradec J, Kharmate G, Hosseini‑Beheshti E, Adomat H, Gleave M, Guns E 
(2014) Reproducibility and efficiency of serum‑derived exosome extrac‑
tion methods. Clin Biochem 47:1286–1292
 41. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al (2011) Identification 
of miRNomes in human liver and hepatocellular carcinoma reveals miR‑
199a/b‑3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 
19:232–243
 42. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J et al (2012) 
Circulating microRNAs in exosomes indicate hepatocyte injury and 
inflammation in alcoholic, drug‑induced, and inflammatory liver diseases. 
Hepatology 56:1946–1957
 43. Postigo AA, Depp JL, Taylor JJ, Kroll KL (2003) Regulation of Smad signal‑
ing through a differential recruitment of coactivators and corepressors by 
ZEB proteins. EMBO J 22:2453–2462
 44. Klein S, Rick J, Schierwagen R, Uschner FE, Strassburg CP, Laleman W et al 
(2014) Jak2/Arhgef1 signaling correlates with severity of liver disease 
and represents a target for therapy of portal hypertension. Hepatology 
60(S1):302A–304A
 45. Small EM, Frost RJ, Olson EN (2010) MicroRNAs add a new dimension to 
cardiovascular disease. Circulation 121:1022–1032
 46. Piano MR (2002) Alcoholic cardiomyopathy: incidence, clinical character‑
istics, and pathophysiology. Chest 121:1638–1650
 47. Alexander J, Mishra P, Desai N, Ambadekar S, Gala B, Sawant P (2007) 
Cirrhotic cardiomyopathy: Indian scenario. J Gastroenterol Hepatol 
22:395–399
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
